EVIO, Inc. (EVIO) is Exceeding Expectations
Investor interest nearly doubles size of placement Company's 2017 revenues soared 438 percent year-over-year On pace to double number of testing facilities this year The regulatory uncertainties surrounding cannabis will have little impact on the long-term growth of the industry. There’s overwhelming scientific evidence validating the medical efficacy of certain cannabinoids and, like all medications, cannabinoids require quality control assurances for potency and purity. Also, much like prohibition, it’s realistic to expect parochial federal regulators to ultimately succumb to the will of the majority and relax any uncertainties around recreational cannabis use. Again, the end product must be tested and…
